Riskpilot← Back to searchSign inGet full accessLILLEENG LEGESENTER AS
ASActiveOrg 916298757Lilleeng 8, 1523 MossGeneral medical practice activities · NACE 8621Est. 20156 employeeswww.lilleenglegesenter.no
Revenue 2024
NOK 5,2M
+11% vs 2023
EBITDA margin
1.1%
+176% vs 2023
Equity ratio
-17.9%
Financial strength
Net profit 2024
NOK 55K
+151% vs 2023
| Revenue | NOK 5,2M | +11% |
| EBITDA | NOK 55K | +176% |
| Net profit | NOK 55K | +151% |
| Total assets | NOK 556K | +62% |
| Equity | NOK -100K | +36% |
| Employees | 6 | — |
Legal name
LILLEENG LEGESENTER AS
Org number
916298757
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. desember 2015
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene eller styrets leder alene.
Company purpose
Driftsselskap for allmennlegesenter.
Address
Lilleeng 8, 1523 Moss
Phone
+4769253545
Email
hans@lilleenglegesenter.no
Website
www.lilleenglegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 210 | 4 557 | 4 244 | 4 677 | 5 210 |
| Staff expenses | −1 354 | −1 881 | −2 178 | −2 254 | −2 375 |
| EBITDA | −83 | 332 | −277 | −73 | 55 |
| Depreciation & amort. | −52 | −35 | −31 | −34 | −0 |
| EBIT | −135 | 297 | −308 | −107 | 55 |
| Net financials | −0 | −2 | 0 | −0 | −0 |
| Profit before tax | −136 | 295 | −308 | −107 | 55 |
| Tax | −25 | 69 | −0 | −0 | −0 |
| Net profit | −111 | 227 | −308 | −107 | 55 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 434 | 820 | 422 | 343 | 556 |
| Equity | 34 | 261 | −48 | −155 | −100 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 400 | 559 | 470 | 498 | 655 |
| Total debt | 400 | 559 | 470 | 498 | 655 |
EBITDA margin
1.1%
This company
15.8%
Market median
-93% vs market
20202024
Equity ratio
-17.9%
This company
38.2%
Market median
-147% vs market
20202024
Return on equity
5515700.0%
This company
18.4%
Market median
+29976530% vs market
20202024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20202024
Asset turnover
9.37×
This company
1.12×
Market median
+737% vs market
20202024
Debt / equity
6.58×
This company
0.62×
Market median
-961% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Company | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LILLEENG LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Kristensen | Board of Directors | 0 companies |